N/A N=2 Presurgical Motor Mapping With Transcranial Magnetic Stimulation (TMS)
Epilepsy
Primary: Average Distance Between Positive Motor Mapping Sites of DCS
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 1 N=17 Prostate SBRT for Locally Recurrent Prostate Cancer After Prior Radiotherapy
Prostate Cancer · Prostatic Neoplasm
Primary: Maximum Tolerated Dose (MTD) — 40; 42.5 gray (Gy)
Phase 3 N=259 A 12-week Extension Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type
Alzheimer's Disease
Primary: Percentage of Participants With Treatment-emergent Adverse Events (TEAEs) by Severity — 20.9; 13.5; 9.2; 19.8 percentage of participants
Phase 2 N=153 Study to Evaluate the Safety, Tolerability, and Efficacy of OTX-CSI in Subjects With Dry Eye Disease.
Dry Eye Disease
Primary: Number of Subjects With At Least One (1) Treatment Emergent Adverse Event — 0; 16; 15; 5 count of participants
Phase 3 N=63 Enhancing Adaptations to Exercise
Inflammation
Primary: Change in Maximum Workload Muscle Strength — 7.5; 3.1 pounds
Phase 2 N=8 A Study of PTC923 (CNSA-001) in Primary Tetrahydrobiopterin (BH4) Deficient Participants With Hyperphenylalaninemia
BH4 Deficiency · Hyperphenylalaninemia
Primary: Number of Participants With Treatment-Emergent Adverse Events (TEAEs) — 2; 2; 4; 3 Participants
N/A N=101 Non-significant Risk Study of a Cochlear Implant Headpiece
Hearing Loss · Sensorineural Hearing Loss
Primary: Subjective Report of Headpiece Comfort and Retention — 65; 70 Participants
N/A N=28 Electroencephalogram (EEG) Study of Inattention Following Treatment With AKL-T01
Attention Deficit Hyperactivity Disorder
Primary: Midline Frontal Theta Power (MFT) — -0.31835; -0.15256; -0.29013 Hertz — p=<0.05
Phase 2 N=43 18F-DOPA-PET/MRI Scan in Imaging Elderly Patients With Newly Diagnosed Grade IV Malignant Glioma or Glioblastoma During Planning for a Short Course of Proton Beam Radiation Therapy
Glioblastoma · Malignant Glioma
Primary: Overall Survival (OS) — 0.54 proportion of successes
Phase 2 N=32 Phase II Trial of Combination Immunotherapy in Subjects With Advanced Small Bowel and Colorectal Cancers
Small Bowel Cancers · Colorectal Cancers
Primary: Objective Response Rate (ORR) for Triple Therapy — 0; 0 Proportion of participants
Phase 3 N=80 Bacterial Decolonization to Prevent Radiation Dermatitis
Radiation Dermatitis
Primary: Number of Participants With Incidence of High Grade Radiation Dermatitis — 0; 9 Participants — p=0.004
N/A N=77 Prospective Observational Analysis Of CR With Sunitinib Treatment In mRCC Patients
Complete Remission in Renal Cell Carcinoma
Primary: Time to Diagnose Metastatic Renal Cell Carcinoma — 3.79; 0.21 Years — p=<0.001
Phase 2 N=134 Effectiveness of Preurodynamic With Posturodynamic Levofloxacin on the Incidence of UTI
Urinary Tract Infections
Primary: Number of Participant With Urinary Tract Infection — 12; 13 Participants
N/A N=144 OPALINE : A Study Of Morbidity And Mortality At 2 Years
Pancreatic Neuroendocrine Tumor, Well Differentiated and Progressive
Primary: Progression-Free Survival (PFS) at 2 Years Assessed by Investigator Per Response Evaluation Criteria in Solid Tumors (RECIST) Version (v) 1.1 - Based on Type of…
N/A N=99 Anterior Colporrhaphy Versus Cystocele Repair Using Polypropylene Mesh or Porcine Dermis
Anterior Vaginal Wall Prolapse · Cystocele · Pelvic Organ Prolapse
Primary: Prospective Randomized Trial of Anterior Colporrhaphy Vs. Cystocele Repair Using Polypropylene Mesh or Porcine Dermis — 5; 14; 12 Participants